Cimetidine

西咪替丁

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCimetidine
Drug Alias Name甲氰咪胍Cimetidinum甲腈咪胍甲腈咪胺西米替丁 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsX-linked ProtoporphyriaDermatitis, AtopicProtoporphyria, Erythropoietic +[6] 
Global Approved IndicationsStomach UlcerGastroesophageal Reflux
Approved Indications in ChinaGastroesophageal Reflux
Original Approved Country/TerritoryUnited States
Original Approved Date1977/08/16
Country/TerritoryUnited StatesIndonesiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesWake Forest University Health SciencesUniversity Of Texas Medical BranchTianjin Lisheng Pharmaceutical Co Ltd +[4] 
Inactive CompaniesGlaxosmithkline PlcFakultas Kedokteran, Universitas Indonesia
Active IndicationsX-linked ProtoporphyriaProtoporphyria, ErythropoieticPeptic Ulcer +[4] 
Inactive IndicationsDermatitis, AtopicStomach Ulcer

Other Information

ATC CodeA02BA01
Related LinksWikipediaDrugBankKEGG